tiprankstipranks
Advertisement
Advertisement

HK:2181 Stock Latest News

Mabpharm Shareholders Unanimously Approve All AGM Resolutions
Company AnnouncementsMabpharm Shareholders Unanimously Approve All AGM Resolutions
8d ago
2181
Mabpharm Wins NMPA Nod for New Denosumab Injection, Eyes Rapid Market Expansion
PremiumCompany Announcements
Mabpharm Wins NMPA Nod for New Denosumab Injection, Eyes Rapid Market Expansion
10d ago
2181
Mabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
PremiumCompany Announcements
Mabpharm Wins China Approval for Denosumab Osteoporosis Drug, Eyes Global Markets
25d ago
2181
Mabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
PremiumCompany Announcements
Mabpharm Sets 2026 AGM, Seeks 10% Share Buyback Mandate
2M ago
2181
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
PremiumCompany Announcements
Mabpharm Moves to Update Constitution for Treasury Shares and Digital Governance
3M ago
2181
Mabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
PremiumCompany AnnouncementsMabpharm Swings to Profit on Surging 2025 Revenue and Strong Gross Margins
3M ago
2181
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
Premium
Company Announcements
Mabpharm Sets March 26 Board Meeting to Approve 2025 Annual Results
4M ago
2181
Mabpharm Limited Announces Board and Committee Restructuring
Premium
Company Announcements
Mabpharm Limited Announces Board and Committee Restructuring
8M ago
2181
Mabpharm Limited Updates Nomination Committee Terms
PremiumCompany Announcements
Mabpharm Limited Updates Nomination Committee Terms
8M ago
2181
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
PremiumCompany Announcements
Mabpharm Limited Reports Strong Interim Financial Results for H1 2025
10M ago
2181
Mabpharm Limited Schedules Board Meeting for Interim Results
PremiumCompany Announcements
Mabpharm Limited Schedules Board Meeting for Interim Results
11M ago
2181
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
PremiumCompany Announcements
Mabpharm Limited Announces Unanimous Approval of AGM Resolutions
1y ago
2181
Mabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
PremiumCompany AnnouncementsMabpharm Limited Announces 2025 Annual General Meeting and Share Repurchase Proposal
1y ago
2181
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
Premium
Company Announcements
Mabpharm Limited Reports Significant Revenue Growth Amidst Financial Challenges
1y ago
2181
Mabpharm Limited Schedules Board Meeting for Annual Results Review
Premium
Company Announcements
Mabpharm Limited Schedules Board Meeting for Annual Results Review
1y ago
2181
Mabpharm Gains Approval in Pakistan for Key Drug
PremiumCompany Announcements
Mabpharm Gains Approval in Pakistan for Key Drug
2y ago
2181
Mabpharm Gains Indonesian Approval for Key Drug
PremiumCompany Announcements
Mabpharm Gains Indonesian Approval for Key Drug
2y ago
2181
Mabpharm Ends Lease Early for Strategic Growth
PremiumCompany Announcements
Mabpharm Ends Lease Early for Strategic Growth
2y ago
2181
Mabpharm Limited Reports Mixed Mid-Year Results
PremiumCompany Announcements
Mabpharm Limited Reports Mixed Mid-Year Results
2y ago
2181
Mabpharm Limited Announces Upcoming Board Meeting
PremiumCompany AnnouncementsMabpharm Limited Announces Upcoming Board Meeting
2y ago
2181
Mabpharm Limited Announces Leadership Reshuffle
Premium
Company Announcements
Mabpharm Limited Announces Leadership Reshuffle
2y ago
2181
Mabpharm’s Core Drug CMAB008 Wins Approval in Peru
Premium
Company Announcements
Mabpharm’s Core Drug CMAB008 Wins Approval in Peru
2y ago
2181

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >